This inventor holds 1 USPTO granted patent. Top assignees: Fuso Pharmaceutical Industries, Ltd., Kinki University, The University of Toyama. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 108 
1 out of 55 
1 out of 38 
Years Active: 2022
Title: Maho Tsubota: Innovator in Pain Management
Introduction
Maho Tsubota is a notable inventor based in Higashiosaka, Japan. He has made significant contributions to the field of pain management through his innovative research and development of new therapeutic agents.
Latest Patents
Maho Tsubota holds a patent for a T-type calcium channel inhibitor, which serves as a new analgesic targeting T-type calcium channels. This invention provides a compound represented by a specific formula, aimed at offering effective therapeutic solutions. The patent also encompasses a medicament containing the T-type calcium channel inhibitor, as well as a therapeutic or prophylactic agent for diseases that benefit from T-type calcium channel inhibition. He has 1 patent to his name.
Career Highlights
Throughout his career, Maho Tsubota has worked with esteemed institutions such as Kinki University and the University of Toyama. His research has focused on developing innovative solutions for pain relief, showcasing his commitment to advancing medical science.
Collaborations
Maho Tsubota has collaborated with notable colleagues, including Atsufumi Kawabata and Fumiko Sekiguchi, who have contributed to his research endeavors.
Conclusion
Maho Tsubota's work in developing a T-type calcium channel inhibitor highlights his innovative approach to pain management. His contributions to the field are significant and demonstrate the potential for new therapeutic options in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile